Ann: Trading Halt, page-48

I don’t doubt you for a minute Tbull and agree that possibly the formal results advice may have just been communicated but I would think the data has probably received continuing evaluation and the outcomes whilst not yet formally notified would have been well known by the clinical team. I think that they would have engaged Taylor Collison at that point to look at business risk around takeovers and opportunities for partnership including financing of Phase 3. I still expect a conjoined Ann with both the test results and the way forward. This is just a personal perspective and please take it at face value.